2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide

C34H57N5O8S — CID 143025108

IUPAC2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide
SMILESC[C@H]1CCN2C(=O)[C@@H](NC(=O)NC3(CS(=O)(=O)C(C)(C)C)CCCCC3)COCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@H]12
InChIInChI=1S/C34H57N5O8S/c1-23-16-19-39-27(23)29(41)36-25(28(40)30(42)35-24-14-15-24)13-9-6-5-7-12-20-47-21-26(31(39)43)37-32(44)38-34(17-10-8-11-18-34)22-48(45,46)33(2,3)4/h23-27H,5-22H2,1-4H3,(H,35,42)(H,36,41)(H2,37,38,44)/t23-,25-,26-,27-/m0/s1
InChIKeyKBPXPNHOGLGLNW-MNUOIFNESA-N
MW695.92 g/mol
LogP2.51
Rot. Bonds7

About 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide

2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide (PubChem CID 143025108) has the molecular formula C34H57N5O8S and a molecular weight of 695.92 g/mol. Its IUPAC name is 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide.

Molecular Properties

Compound Name2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide
PubChem CID143025108
Molecular FormulaC34H57N5O8S
Molecular Weight695.92 g/mol
Exact Mass695.39
IUPAC Name2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide
SMILESC[C@H]1CCN2C(=O)[C@@H](NC(=O)NC3(CS(=O)(=O)C(C)(C)C)CCCCC3)COCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@H]12
InChIInChI=1S/C34H57N5O8S/c1-23-16-19-39-27(23)29(41)36-25(28(40)30(42)35-24-14-15-24)13-9-6-5-7-12-20-47-21-26(31(39)43)37-32(44)38-34(17-10-8-11-18-34)22-48(45,46)33(2,3)4/h23-27H,5-22H2,1-4H3,(H,35,42)(H,36,41)(H2,37,38,44)/t23-,25-,26-,27-/m0/s1
InChIKeyKBPXPNHOGLGLNW-MNUOIFNESA-N
XLogP2.51
TPSA180.08 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms48
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500695.92
LogP ≤ 52.51
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide?
The IUPAC name of 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide (CID 143025108) is 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide.
What is the SMILES notation for 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide?
The canonical SMILES for 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide is C[C@H]1CCN2C(=O)[C@@H](NC(=O)NC3(CS(=O)(=O)C(C)(C)C)CCCCC3)COCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@H]12.
What is the InChIKey of 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide?
The InChIKey is KBPXPNHOGLGLNW-MNUOIFNESA-N. The full InChI is InChI=1S/C34H57N5O8S/c1-23-16-19-39-27(23)29(41)36-25(28(40)30(42)35-24-14-15-24)13-9-6-5-7-12-20-47-21-26(31(39)43)37-32(44)38-34(17-10-8-11-18-34)22-48(45,46)33(2,3)4/h23-27H,5-22H2,1-4H3,(H,35,42)(H,36,41)(H2,37,38,44)/t23-,25-,26-,27-/m0/s1.
What are the key properties of 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide?
2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide has a molecular weight of 695.92 g/mol, XLogP of 2.51, 7 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S,13S,16S,17S)-3-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-17-methyl-2,15-dioxo-5-oxa-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-N-cyclopropyl-2-oxoacetamide is sourced from PubChem (CID 143025108), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).